Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BCAL Diagnostics Limited (AU:BDX)
ASX:BDX
BCAL Diagnostics Limited (BDX) Share Price & Analysis
0 Followers
BDX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.07 - AU$0.21
Previous CloseAU$0.1
Volume7.29K
Average Volume (3M)285.40K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)AU$9.57M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-4.2
Beta0.25
Next Earnings
Aug 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume285,399
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BCAL Diagnostics Limited News
PremiumCompany Announcements
BCAL Diagnostics Advances Breast Cancer Detection TestOptions Prices
Currently, No data available
---
Ownership Overview
26.25% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
73.75% Public Companies and
Individual Investors
BDX FAQ
What was BCAL Diagnostics Limited’s price range in the past 12 months?
BCAL Diagnostics Limited lowest share price was AU$0.07 and its highest was AU$0.21 in the past 12 months.
What is BCAL Diagnostics Limited’s market cap?
Currently, no data Available
When is BCAL Diagnostics Limited’s upcoming earnings report date?
BCAL Diagnostics Limited’s upcoming earnings report date is Aug 27, 2024 which is in 121 days.
How were BCAL Diagnostics Limited’s earnings last quarter?
BCAL Diagnostics Limited released its earnings results on Feb 20, 2024. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.01.
Is BCAL Diagnostics Limited overvalued?
According to Wall Street analysts BCAL Diagnostics Limited’s price is currently Overvalued.
Does BCAL Diagnostics Limited pay dividends?
BCAL Diagnostics Limited does not currently pay dividends.
What is BCAL Diagnostics Limited’s EPS estimate?
BCAL Diagnostics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BCAL Diagnostics Limited have?
BCAL Diagnostics Limited has 252,294,710 shares outstanding.
What happened to BCAL Diagnostics Limited’s price movement after its last earnings report?
BCAL Diagnostics Limited reported an EPS of -AU$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BCAL Diagnostics Limited?
Currently, no hedge funds are holding shares in AU:BDX
---
BCAL Diagnostics Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-73.51%
Trailing 12-Months
Asset Growth
6.14%
Trailing 12-Months
Company Description
BCAL Diagnostics Limited
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
---
Technical Analysis
---